Global PD-1 And PD-L1 Inhibitors Market Report By Type (PD-1,PD-L1), By Application (Head and neck cancers,Hodgkin lymphoma,Kidney cancer,Melanoma of the skin,Non-small cell lung cancer) And By Regions - Industry Trends, Size, Share, Growth, Estimation and Forecast, 2020-2027

ID:VMR11213687
October 2020
Report Formats:
The global demand for PD-1 And PD-L1 Inhibitors Market is presumed to reach the valuation of nearly USD XX MN by 2027 from USD XX MN in 2020 with a CAGR of XX% under the study period of 2020 - 2027. 

PD-1 inhibitors and PD-L1 inhibitors refer to a group of checkpoint inhibitor anticancer drugs. It blocks the action of PD-1 and PDL1 immune checkpoint proteins there on the surface of cells. Immune checkpoint inhibitors are emerging as a cutting edge treatment for numerous types of cancer. The immune checkpoints are responsible for reducing antitumor immune responses. Some examples include atezolizumab, avelumab, Bavencio, cemiplimab, durvalumab, Imfinzi, and others. PD-1 binds to PD-L1 and tells the T cell or immune cells to leave the other cell alone. In the cancer disease state, the PD-L1 on the tumor cells interaction with PD-1 on a T-cell minimizes T-cell function signals to avert the immune system from attacking the tumor cells.

Market Dynamics

The rising prevalence rate of various types of cancer worldwide is the primary factor driving the PD-1 and PD-l1 inhibitors market. The PD-1/PD-L1 Inhibitors promise improved survival of patients with low toxicity is a considerable market driving factor, contributing to the pd-1 and pd-l1 inhibitors market's growth. Also, the rapid rise in FDA approval of PD-L1 inhibitors is positively impacting the growth of the pd-1 and pd-L1 inhibitors market. A rise in investments in the PD-1 and PD-L1 inhibitors market for finding better immuno-oncology therapies for colon cancer, renal cell cancer, non-small cell lung cancer (NSCLC), and melanoma, is expected to offer profitable growth opportunities for key players of the Pd-1 and PD-L1 inhibitors market in the coming years

The report covers Porter’s Five Forces Model, Market Attractiveness Analysis and Value Chain analysis. These tools help to get a clear picture of the industry’s structure and evaluate the competition attractiveness at a global level.

Additionally, these tools also give inclusive assessment of each segment in the global market of pd-1 and pd-l1 inhibitors.

Market Segmentation

The report segments the pd-1 and pd-l1 inhibitors market and analyses it with respect to the geography, intending to keep the marketer informed and help them identify the target demographics for the product or service.

By Type
  • PD-1
  • PD-L1

By Application
  • Head and neck cancers
  • Hodgkin lymphoma
  • Kidney cancer
  • Melanoma of the skin
  • Non-small cell lung cancer

Regional Analysis

This section covers regional segmentation which accentuates on current and future demand for pd-1 and pd-l1 inhibitors market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand for individual application segment across all the prominent regions.

Europe PD-1 And PD-L1 Inhibitors Market by Revenue (USD MN)



The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the pd-1 and pd-l1 inhibitors market include Bristol-Myers Squibb, Merck & Co., F. Hoffmann-La Roche AG, Sanofi, Amgen, Gilead Sciences, AstraZeneca, Novartis, Pfizer, Celgene.S. This section includes a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.
 
METHODOLOGY:

This market research report has been produced by gathering information on the basis of primary and secondary research. Secondary research has been done by using various sources which include (but not limited to) Company Websites, Paid Data Sources,  Technical Journals, Financial Reports, SEC Filings, and other different industry publications. 

If specific information is required which is not currently within the scope of the report, it can be provided as a part of customization.

1 . PREFACE
       1.1. Report Description
           1.1.1. Objective
           1.1.2. Target Audience
           1.1.3. Unique Selling Proposition (USP) & offerings
       1.2. Research Scope
       1.3. Research Methodology
           1.3.1. Market Research Process
           1.3.2. Market Research Methodology
 
2 . EXECUTIVE SUMMARY
       2.1. Highlights of PD-1 and PD-L1 Inhibitors Market
       2.2. Global PD-1 and PD-L1 Inhibitors Market Snapshot
 
3 . PD-1 AND PD-L1 INHIBITORS – INDUSTRY ANALYSIS
       3.1. Introduction
       3.2. Market Drivers of PD-1 and PD-L1 Inhibitors Market
       3.3. Market Restraints of PD-1 and PD-L1 Inhibitors Market
       3.4. Opportunities of PD-1 and PD-L1 Inhibitors Market
       3.5. Trends of PD-1 and PD-L1 Inhibitors Market
       3.6. Porter’s Five Force Analysis of PD-1 and PD-L1 Inhibitors Market
       3.7. PD-1 and PD-L1 Inhibitors Market Attractiveness Analysis
           3.7.1 Market Attractive Analysis by Type
           3.7.2 Market Attractive Analysis by Application
           3.7.3 Market Attractive Analysis by Region
 
4 . VALUE CHAIN ANALYSIS
       4.1. PD-1 and PD-L1 Inhibitors Value Chain Analysis
       4.2. PD-1 and PD-L1 Inhibitors Raw Material Analysis
           4.2.1. List of Raw Materials
           4.2.2. PD-1 and PD-L1 Inhibitors Raw Material Manufactures List
           4.2.3. Price Trend of PD-1 and PD-L1 Inhibitors Key Raw Materials
       4.3. List of Potential Buyers
       4.4. Marketing Channel
           4.4.1. Direct Marketing
           4.4.2. Indirect Marketing
           4.4.3. Marketing Channel Development Trend
 
5 . IMPACT ANALYSIS OF COVID-19 OUTBREAK
       5.1. Impact Analysis of Covid-19 Outbreak on PD-1 and PD-L1 Inhibitors Market
           5.1.1. Direct Impact on Production
           5.1.2. Supply Chain and Market Disruption
           5.1.3. Financial Impact on Firms and Financial Markets
       5.2. COVID-19 Impact Analysis by Production, Import, Export and Demand
       5.3. PD-1 and PD-L1 Inhibitors Market: Pre V/S Post COVID-19
       5.4. Estimated Impact of the Coronavirus (COVID-19) Epidemic on the PD-1 and PD-L1 Inhibitors Market
       5.5. COVID-19: Micro and Macro Factor Analysis on PD-1 and PD-L1 Inhibitors Market
 
6 . GLOBAL PD-1 AND PD-L1 INHIBITORS MARKET ANALYSIS BY TYPE
       6.1 Overview by Type
       6.2 Historical Data 2016-2019
       6.3 Global PD-1 and PD-L1 Inhibitors Market Analysis by Type
       6.4 Market Analysis of PD-1 by Regions
       6.6 Market Analysis of PD-L1 by Regions
 
7 . GLOBAL PD-1 AND PD-L1 INHIBITORS MARKET ANALYSIS BY APPLICATION
       7.1 Overview by Application
       7.2 Historical Data 2016-2019
       7.3 Global PD-1 and PD-L1 Inhibitors Market Analysis by Application
       7.4 Market Analysis of Head and Neck Cancers by Regions
       7.5 Market Analysis of Hodgkin Lymphoma by Regions
       7.6 Market Analysis of Kidney Cancer by Regions
       7.7 Market Analysis of Melanoma of the Skin by Regions
       7.8 Market Analysis of Non-Small Cell Lung Cancer by Regions
 
8 . GLOBAL PD-1 AND PD-L1 INHIBITORS MARKET ANALYSIS BY GEOGRAPHY
       8.1. Regional Outlook
       8.2. Introduction
       8.3. North America
           8.3.1. Overview and Historic Data
           8.3.2. North America PD-1 and PD-L1 Inhibitors Market Estimate By Market Segment
           8.3.3. North America PD-1 and PD-L1 Inhibitors Market Estimate By Country
           8.3.4. United State
           8.3.5. Canada
           8.3.6. Mexico
       8.4. Europe
           8.4.1. Overview and Historic Data
           8.4.2. Europe PD-1 and PD-L1 Inhibitors Market Estimate by Market Segment
           8.4.3. Europe PD-1 and PD-L1 Inhibitors Market Estimate by Country
           8.4.4. United Kingdom
           8.4.5. France
           8.4.6. Germany
           8.4.7. Italy
           8.4.8. Russia
           8.4.9. Rest Of Europe
       8.5. Asia Pacific
           8.5.1. Overview and Historic Data
           8.5.2. Asia Pacific PD-1 and PD-L1 Inhibitors Market Estimate by Market Segment
           8.5.3. Asia Pacific PD-1 and PD-L1 Inhibitors Market Estimate by Country
           8.5.4. China
           8.5.5. India
           8.5.6. Japan
           8.5.7. South Korea
           8.5.8. Australia
           8.5.9. Rest Of Asia Pacific
       8.6. Latin America
           8.6.1. Overview and Historic Data
           8.6.2. Latin America PD-1 and PD-L1 Inhibitors Market Estimate by Market Segment
           8.6.3. Latin America PD-1 and PD-L1 Inhibitors Market Estimate by Country
           8.6.4. Brazil
           8.6.5. Argentina
           8.6.6. Peru
           8.6.7. Chile
           8.6.8. Rest of Latin America
       8.7. Middle East & Africa
           8.7.1. Overview and Historic Data
           8.7.2. Middle East & Africa PD-1 and PD-L1 Inhibitors Market Estimate by Market Segment
           8.7.3. Middle East & Africa PD-1 and PD-L1 Inhibitors Market Estimate by Country
           8.7.4. Saudi Arabia
           8.7.5. UAE
           8.7.6. Israel
           8.7.7. South Africa
           8.7.8. Rest Of Middle East And Africa
 
9 . COMPETITIVE LANDSCAPE OF THE PD-1 AND PD-L1 INHIBITORS COMPANIES
       9.1. PD-1 and PD-L1 Inhibitors Market Competition
       9.2. Partnership/Collaboration/Agreement
       9.3. Merger And Acquisitions
       9.4. New Product Launch
       9.5. Other Developments
 
10 . COMPANY PROFILES OF PD-1 AND PD-L1 INHIBITORS INDUSTRY
       10.1. Company Share Analysis
       10.2. Market Concentration Rate
       10.3. Bristol-Myers Squibb
           10.3.1. Company Overview
           10.3.2. Financials
           10.3.3. Products
           10.3.4. Recent Developments
       10.4. Merck & Co.
           10.4.1. Company Overview
           10.4.2. Financials
           10.4.3. Products
           10.4.4. Recent Developments
       10.5. F. Hoffmann-La Roche AG
           10.5.1. Company Overview
           10.5.2. Financials
           10.5.3. Products
           10.5.4. Recent Developments
       10.6. Sanofi
           10.6.1. Company Overview
           10.6.2. Financials
           10.6.3. Products
           10.6.4. Recent Developments
       10.7. Amgen
           10.7.1. Company Overview
           10.7.2. Financials
           10.7.3. Products
           10.7.4. Recent Developments
       10.8. Gilead Sciences
           10.8.1. Company Overview
           10.8.2. Financials
           10.8.3. Products
           10.8.4. Recent Developments
       10.9. AstraZeneca
           10.9.1. Company Overview
           10.9.2. Financials
           10.9.3. Products
           10.9.4. Recent Developments
       10.10. Novartis
           10.10.1. Company Overview
           10.10.2. Financials
           10.10.3. Products
           10.10.4. Recent Developments
       10.11. Pfizer
           10.11.1. Company Overview
           10.11.2. Financials
           10.11.3. Products
           10.11.4. Recent Developments
       10.12. Celgene
           10.12.1. Company Overview
           10.12.2. Financials
           10.12.3. Products
           10.12.4. Recent Developments
 
 *Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies
 
LIST OF TABLES

  • Global PD-1 and PD-L1 Inhibitors Market Snapshot
  • Drivers of The Global PD-1 and PD-L1 Inhibitors Market Impact Analysis
  • Restraints of The Global PD-1 and PD-L1 Inhibitors Market Impact Analysis
  • List of Raw Material
  • List of Raw Material Manufactures
  • List of Potential Buyers
  • COVID-19 Impact Analysis by Production, Import, Export and Demand
  • PD-1 and PD-L1 Inhibitors Market: Pre V/S Post COVID-19
  • Estimated Impact Of The Coronavirus (Covid-19) Epidemic On The PD-1 and PD-L1 Inhibitors Market
  • COVID-19: Micro and Macro Factor Analysis on PD-1 and PD-L1 Inhibitors Market
  • Global PD-1 and PD-L1 Inhibitors Market Analysis by Type ( USD MN)
  • Historic Data 2016-2019
  • Global PD-1 and PD-L1 Inhibitors Market Analysis in PD-1 by Geography ( USD MN)
  • Global PD-1 and PD-L1 Inhibitors Market Analysis in PD-L1 by Geography ( USD MN)
  • Global PD-1 and PD-L1 Inhibitors Market Analysis by Application ( USD MN)
  • Historic Data 2016-2019
  • Global PD-1 and PD-L1 Inhibitors Market Analysis in Head and Neck Cancers by Geography ( USD MN)
  • Global PD-1 and PD-L1 Inhibitors Market Analysis in Hodgkin Lymphoma by Geography ( USD MN)
  • Global PD-1 and PD-L1 Inhibitors Market Analysis in Kidney Cancer by Geography ( USD MN)
  • Global PD-1 and PD-L1 Inhibitors Market Analysis in Melanoma of the Skin by Geography ( USD MN)
  • Global PD-1 and PD-L1 Inhibitors Market Analysis in Non-Small Cell Lung Cancer by Geography ( USD MN)
  • Global PD-1 and PD-L1 Inhibitors Market by Geography ( USD MN)
  • Historic Data 2016-2019
  • North America PD-1 and PD-L1 Inhibitors Market Analysis by Type ( USD MN)
  • North America PD-1 and PD-L1 Inhibitors Market Estimate by Application ( USD MN)
  • North America PD-1 and PD-L1 Inhibitors Market Estimate by Country ( USD MN)
  • United State PD-1 and PD-L1 Inhibitors Market Analysis by Type ( USD MN)
  • United State PD-1 and PD-L1 Inhibitors Market Estimate by Application ( USD MN)
  • Canada PD-1 and PD-L1 Inhibitors Market Analysis by Type ( USD MN)
  • Canada PD-1 and PD-L1 Inhibitors Market Estimate by Application ( USD MN)
  • Mexico PD-1 and PD-L1 Inhibitors Market Analysis by Type ( USD MN)
  • Mexico PD-1 and PD-L1 Inhibitors Market Estimate by Application ( USD MN)
  • Europe PD-1 and PD-L1 Inhibitors Market Analysis by Type ( USD MN)
  • Europe PD-1 and PD-L1 Inhibitors Market Estimate by Application ( USD MN)
  • Europe PD-1 and PD-L1 Inhibitors Market Estimate by Country ( USD MN)
  • United Kingdom PD-1 and PD-L1 Inhibitors Market Analysis by Type ( USD MN)
  • United Kingdom PD-1 and PD-L1 Inhibitors Market Estimate by Application ( USD MN)
  • France PD-1 and PD-L1 Inhibitors Market Analysis by Type ( USD MN)
  • France PD-1 and PD-L1 Inhibitors Market Estimate by Application ( USD MN)
  • Germany PD-1 and PD-L1 Inhibitors Market Analysis by Type ( USD MN)
  • Germany PD-1 and PD-L1 Inhibitors Market Estimate by Application ( USD MN)
  • Italy PD-1 and PD-L1 Inhibitors Market Analysis by Type ( USD MN)
  • Italy PD-1 and PD-L1 Inhibitors Market Estimate by Application ( USD MN)
  • Russia PD-1 and PD-L1 Inhibitors Market Analysis by Type ( USD MN)
  • Russia PD-1 and PD-L1 Inhibitors Market Estimate by Application ( USD MN)
  • Spain PD-1 and PD-L1 Inhibitors Market Analysis by Type ( USD MN)
  • Spain PD-1 and PD-L1 Inhibitors Market Estimate by Application ( USD MN)
  • Rest of Europe PD-1 and PD-L1 Inhibitors Market Analysis by Type ( USD MN)
  • Rest of Europe PD-1 and PD-L1 Inhibitors Market Estimate by Application ( USD MN)
  • Asia Pacific PD-1 and PD-L1 Inhibitors Market Analysis by Type ( USD MN)
  • Asia Pacific PD-1 and PD-L1 Inhibitors Market Estimate by Application ( USD MN)
  • Asia Pacific PD-1 and PD-L1 Inhibitors Market Estimate by Country ( USD MN)
  • China PD-1 and PD-L1 Inhibitors Market Analysis by Type ( USD MN)
  • China PD-1 and PD-L1 Inhibitors Market Estimate by Application ( USD MN)
  • Japan PD-1 and PD-L1 Inhibitors Market Analysis by Type ( USD MN)
  • Japan PD-1 and PD-L1 Inhibitors Market Estimate by Application ( USD MN)
  • India PD-1 and PD-L1 Inhibitors Market Analysis by Type ( USD MN)
  • India PD-1 and PD-L1 Inhibitors Market Estimate by Application ( USD MN)
  • South Korea PD-1 and PD-L1 Inhibitors Market Analysis by Type ( USD MN)
  • South Korea PD-1 and PD-L1 Inhibitors Market Estimate by Application ( USD MN)
  • Australia PD-1 and PD-L1 Inhibitors Market Analysis by Type ( USD MN)
  • Australia PD-1 and PD-L1 Inhibitors Market Estimate by Application ( USD MN)
  • Rest of Asia Pacific PD-1 and PD-L1 Inhibitors Market Analysis by Type ( USD MN)
  • Rest of Asia Pacific PD-1 and PD-L1 Inhibitors Market Estimate by Application ( USD MN)
  • Latin America PD-1 and PD-L1 Inhibitors Market Analysis by Type ( USD MN)
  • Latin America PD-1 and PD-L1 Inhibitors Market Estimate by Application ( USD MN)
  • Latin America PD-1 and PD-L1 Inhibitors Market Estimate by Country ( USD MN)
  • Brazil PD-1 and PD-L1 Inhibitors Market Analysis by Type ( USD MN)
  • Brazil PD-1 and PD-L1 Inhibitors Market Estimate by Application ( USD MN)
  • Argentina PD-1 and PD-L1 Inhibitors Market Analysis by Type ( USD MN)
  • Argentina PD-1 and PD-L1 Inhibitors Market Estimate by Application ( USD MN)
  • Peru PD-1 and PD-L1 Inhibitors Market Analysis by Type ( USD MN)
  • Peru PD-1 and PD-L1 Inhibitors Market Estimate by Application ( USD MN)
  • Chile PD-1 and PD-L1 Inhibitors Market Analysis by Type ( USD MN)
  • Chile PD-1 and PD-L1 Inhibitors Market Estimate by Application ( USD MN)
  • Rest of Latin America PD-1 and PD-L1 Inhibitors Market Analysis by Type ( USD MN)
  • Rest of Latin America PD-1 and PD-L1 Inhibitors Market Estimate by Application ( USD MN)
  • Middle East & Africa PD-1 and PD-L1 Inhibitors Market Analysis by Type ( USD MN)
  • Middle East & Africa PD-1 and PD-L1 Inhibitors Market Estimate by Application ( USD MN)
  • Middle East & Africa PD-1 and PD-L1 Inhibitors Market Estimate by Country ( USD MN)
  • Saudi Arabia PD-1 and PD-L1 Inhibitors Market Analysis by Type ( USD MN)
  • Saudi Arabia PD-1 and PD-L1 Inhibitors Market Estimate by Application ( USD MN)
  • UAE PD-1 and PD-L1 Inhibitors Market Analysis by Type ( USD MN)
  • UAE PD-1 and PD-L1 Inhibitors Market Estimate by Application ( USD MN)
  • Israel PD-1 and PD-L1 Inhibitors Market Analysis by Type ( USD MN)
  • Israel PD-1 and PD-L1 Inhibitors Market Estimate by Application ( USD MN)
  • South Africa PD-1 and PD-L1 Inhibitors Market Analysis by Type ( USD MN)
  • South Africa PD-1 and PD-L1 Inhibitors Market Estimate by Application ( USD MN)
  • Rest of Middle East and Africa PD-1 and PD-L1 Inhibitors Market Analysis by Type ( USD MN)
  • Rest of Middle East and Africa PD-1 and PD-L1 Inhibitors Market Estimate by Application ( USD MN)
  • Partnership/Collaboration/Agreement
  • Mergers And Acquisiton
 
LIST OF FIGURES
 
  • Research Scope of PD-1 and PD-L1 Inhibitors Report
  • Market Research Process
  • Market Research Methodology
  • Global PD-1 and PD-L1 Inhibitors Market Size, by Region
  • Porters Five Forces Analysis
  • Market Attractiveness Analysis by Type
  • Market Attractiveness Analysis by Application
  • Market Attractiveness Analysis by Region
  • Value Chain Analysis
  • Global PD-1 and PD-L1 Inhibitors Market Analysis by Type
  • Global PD-1 and PD-L1 Inhibitors Market Analysis in PD-1 by Region
  • Global PD-1 and PD-L1 Inhibitors Market Analysis in PD-L1 by Region
  • Global PD-1 and PD-L1 Inhibitors Market Analysis by Application
  • Global PD-1 and PD-L1 Inhibitors Market Analysis in Head and Neck Cancers by Region
  • Global PD-1 and PD-L1 Inhibitors Market Analysis in Hodgkin Lymphoma by Region
  • Global PD-1 and PD-L1 Inhibitors Market Analysis in Kidney Cancer by Region
  • Global PD-1 and PD-L1 Inhibitors Market Analysis in Melanoma of the Skin by Region
  • Global PD-1 and PD-L1 Inhibitors Market Analysis in Non-Small Cell Lung Cancer by Region
  • Global PD-1 and PD-L1 Inhibitors Market by Revenue
  • North America PD-1 and PD-L1 Inhibitors Market by Revenue
  • Europe PD-1 and PD-L1 Inhibitors Market by Revenue
  • Asia Pacific PD-1 and PD-L1 Inhibitors Market by Revenue
  • Latin America PD-1 and PD-L1 Inhibitors Market by Revenue
  • Middle East & Africa PD-1 and PD-L1 Inhibitors Market by Revenue
  • Recent Development in PD-1 and PD-L1 Inhibitors Industry
  • Company Market Share Analysis, 2020
 
* Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.

Buy Chapters or Sections

Avail customized purchase options to meet your exact research needs:

  • Buy sections of this report
  • Buy country level reports
  • Request for historical data
  • Request discounts available for Start-Ups & Universities

Objectives of Study

  • Define and measure the global market
  • Volume or revenue forecast of the global market and its various sub-segments with respect to main geographies
  • Analyze and identify major market trends along with the factors driving or inhibiting the market growth
  • Study the company profiles of the major market players with their market share
  • Analyze competitive developments

Why Choose Us

Client First Policy
Excellent Quality
Robust After Sales Support
24/7 Email Support

Clients

Testimonials